Our Foundation
Where We've Been.
Laura Spring, MD Massachusetts General Hospital Localized breast cancer patients with higher risk disease are often treated with chemotherapy in the neoadjuvant (before surgery) setting. However, it is difficult to predict how breast cancer will respond to treatment given in the neoadjuvant setting and we currently lack any specific blood tests to help answer this […]
Jing Hu, PhD Memorial Sloan Kettering Cancer Center Metastasis is a major clinical hurdle in breast cancer treatment, with poor prognosis (5-year survival around 26.5%). Despite surgical resection of the primary tumor and systemic therapy to suppress residual disease, distant metastatic relapse may still occur within a few months to years, implying the existence of […]
Veerle Daniels, PhD Dana-Farber Cancer Institute Despite recent advances in treatment options, breast cancer remains the second leading cause of cancer-related deaths in women. Triple negative breast cancer (TNBC) is a subgroup of breast cancer that is characterized by the absence of the estrogen receptor, the progesterone receptor and HER2-amplification. Because of the lack of these […]
Ana Garrido-Castro, MD Dana-Farber Cancer Institute Choosing the best treatments for metastatic breast cancer depends increasingly on molecular features, such as tumor subtype. Patients with hormone receptor-positive/HER2-negative breast cancer are typically treated initially with hormonal therapies, and then subsequently with chemotherapy once hormonal therapy loses its effectiveness. Loss of hormone receptor expression has been described as a […]
College student is link between researchers and scientific advisory board By KATHLEEN EDGECOMB Gabby Gualtieri was 10 or 11 when she first became involved with the Terri Brodeur Breast Cancer Foundation. She remembers handing out drinks, snacks and candy with her family to participants during the annual Walk Across Southeastern Connecticut fundraiser. “The marathon was […]
Director of Development and Outreach Terri Brodeur Breast Cancer Foundation – New London, CT 06320 We have an exciting part-time opportunity for a Director of Development and Outreach to be part of an organization whose goal is to find a cure for breast cancer. Read Job Description To apply for the position please send your resume to [email protected] […]
Dear Supporters, During this busy time of year, we hope you are all able to celebrate the spirit of the season with your loved ones. In this final newsletter issue for 2018, our top stories focus on the foundation’s grant process and place a spotlight on the incredible generosity of two of our top supporters. […]
2018 has been Pamela Morris Watt’s year to shine By SANDY MANISCALCO As of this writing, Watt and Pam’s Pink Posse have raised nearly $25,000 for the 13th Annual Walk Across Southeastern CT. This is an all-time record. On December 19, Arooga Grille House & Sports Bar staff presented Watt with a check for the […]
Scientific Advisory Board reviewing grant applications By KATHLEEN EDGECOMB The Terri Brodeur Breast Cancer Foundation, which annually raises more than $300,000 that directly funds three $100,000 research grants, will award four grants in 2019. It is the fifth time in the organizations 13-year history that four grants will be handed out. The foundation raises money […]
Mass General researcher Dr. Sheng Sun gives TBBCF members an update By KATHLEEN EDGECOMB A few years ago, the doctors at the Center for Breast Cancer at Massachusetts General Hospital treated a 56-year-old woman with breast cancer who had no identifiable abnormalities to put her at high risk for recurrence. But two years later, the […]
